nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—Nodule—Lovastatin—atherosclerosis	0.0331	0.0501	CcSEcCtD
Pentazocine—Nodule—Simvastatin—atherosclerosis	0.031	0.0468	CcSEcCtD
Pentazocine—Nodule—Pravastatin—atherosclerosis	0.028	0.0423	CcSEcCtD
Pentazocine—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00809	0.0122	CcSEcCtD
Pentazocine—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00757	0.0114	CcSEcCtD
Pentazocine—Hepatic function abnormal—Niacin—atherosclerosis	0.00695	0.0105	CcSEcCtD
Pentazocine—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00684	0.0103	CcSEcCtD
Pentazocine—Cramp muscle—Lovastatin—atherosclerosis	0.00637	0.00962	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00637	0.00962	CcSEcCtD
Pentazocine—Cramp muscle—Ezetimibe—atherosclerosis	0.00624	0.00943	CcSEcCtD
Pentazocine—Eosinophilia—Lovastatin—atherosclerosis	0.00605	0.00914	CcSEcCtD
Pentazocine—Diplopia—Pravastatin—atherosclerosis	0.00598	0.00903	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00595	0.009	CcSEcCtD
Pentazocine—Cramp muscle—Simvastatin—atherosclerosis	0.00595	0.009	CcSEcCtD
Pentazocine—Eosinophilia—Ezetimibe—atherosclerosis	0.00593	0.00896	CcSEcCtD
Pentazocine—Face oedema—Niacin—atherosclerosis	0.00586	0.00886	CcSEcCtD
Pentazocine—Abdominal discomfort—Lovastatin—atherosclerosis	0.00586	0.00885	CcSEcCtD
Pentazocine—Urinary retention—Niacin—atherosclerosis	0.00577	0.00872	CcSEcCtD
Pentazocine—Eosinophilia—Simvastatin—atherosclerosis	0.00566	0.00855	CcSEcCtD
Pentazocine—Abdominal discomfort—Simvastatin—atherosclerosis	0.00548	0.00828	CcSEcCtD
Pentazocine—Cramp muscle—Pravastatin—atherosclerosis	0.00538	0.00813	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00538	0.00813	CcSEcCtD
Pentazocine—Eosinophilia—Pravastatin—atherosclerosis	0.00512	0.00773	CcSEcCtD
Pentazocine—Sweating increased—Pravastatin—atherosclerosis	0.00503	0.0076	CcSEcCtD
Pentazocine—Erythema multiforme—Lovastatin—atherosclerosis	0.00462	0.00699	CcSEcCtD
Pentazocine—Flushing—Lovastatin—atherosclerosis	0.00454	0.00686	CcSEcCtD
Pentazocine—Erythema multiforme—Ezetimibe—atherosclerosis	0.00453	0.00685	CcSEcCtD
Pentazocine—Sweating—Niacin—atherosclerosis	0.00449	0.00678	CcSEcCtD
Pentazocine—Flushing—Ezetimibe—atherosclerosis	0.00445	0.00673	CcSEcCtD
Pentazocine—Chills—Lovastatin—atherosclerosis	0.00439	0.00663	CcSEcCtD
Pentazocine—Erythema multiforme—Simvastatin—atherosclerosis	0.00432	0.00653	CcSEcCtD
Pentazocine—Flushing—Simvastatin—atherosclerosis	0.00425	0.00641	CcSEcCtD
Pentazocine—Dysgeusia—Lovastatin—atherosclerosis	0.00417	0.0063	CcSEcCtD
Pentazocine—Confusional state—Rosuvastatin—atherosclerosis	0.00413	0.00625	CcSEcCtD
Pentazocine—Chills—Simvastatin—atherosclerosis	0.0041	0.0062	CcSEcCtD
Pentazocine—Muscle spasms—Lovastatin—atherosclerosis	0.00409	0.00618	CcSEcCtD
Pentazocine—Visual impairment—Niacin—atherosclerosis	0.00405	0.00612	CcSEcCtD
Pentazocine—Muscle spasms—Ezetimibe—atherosclerosis	0.00401	0.00607	CcSEcCtD
Pentazocine—Vision blurred—Lovastatin—atherosclerosis	0.00401	0.00606	CcSEcCtD
Pentazocine—Tremor—Lovastatin—atherosclerosis	0.00399	0.00603	CcSEcCtD
Pentazocine—Visual impairment—Pravastatin—atherosclerosis	0.00399	0.00602	CcSEcCtD
Pentazocine—Tinnitus—Niacin—atherosclerosis	0.00392	0.00592	CcSEcCtD
Pentazocine—Erythema multiforme—Pravastatin—atherosclerosis	0.00391	0.00591	CcSEcCtD
Pentazocine—Dysgeusia—Simvastatin—atherosclerosis	0.0039	0.00589	CcSEcCtD
Pentazocine—Flushing—Niacin—atherosclerosis	0.0039	0.00589	CcSEcCtD
Pentazocine—Tinnitus—Pravastatin—atherosclerosis	0.00386	0.00583	CcSEcCtD
Pentazocine—Flushing—Pravastatin—atherosclerosis	0.00384	0.0058	CcSEcCtD
Pentazocine—Muscle spasms—Simvastatin—atherosclerosis	0.00383	0.00578	CcSEcCtD
Pentazocine—Vertigo—Lovastatin—atherosclerosis	0.00382	0.00578	CcSEcCtD
Pentazocine—Chills—Niacin—atherosclerosis	0.00377	0.00569	CcSEcCtD
Pentazocine—Vision blurred—Simvastatin—atherosclerosis	0.00375	0.00567	CcSEcCtD
Pentazocine—Tremor—Simvastatin—atherosclerosis	0.00373	0.00564	CcSEcCtD
Pentazocine—Chills—Pravastatin—atherosclerosis	0.00371	0.00561	CcSEcCtD
Pentazocine—Insomnia—Rosuvastatin—atherosclerosis	0.00371	0.0056	CcSEcCtD
Pentazocine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00368	0.00556	CcSEcCtD
Pentazocine—Hypertension—Ezetimibe—atherosclerosis	0.0036	0.00545	CcSEcCtD
Pentazocine—Vertigo—Simvastatin—atherosclerosis	0.00358	0.00541	CcSEcCtD
Pentazocine—Dry mouth—Lovastatin—atherosclerosis	0.00354	0.00536	CcSEcCtD
Pentazocine—Dysgeusia—Pravastatin—atherosclerosis	0.00353	0.00533	CcSEcCtD
Pentazocine—Muscle spasms—Niacin—atherosclerosis	0.00352	0.00531	CcSEcCtD
Pentazocine—Constipation—Rosuvastatin—atherosclerosis	0.00351	0.0053	CcSEcCtD
Pentazocine—Confusional state—Lovastatin—atherosclerosis	0.0035	0.00529	CcSEcCtD
Pentazocine—Dry mouth—Ezetimibe—atherosclerosis	0.00348	0.00525	CcSEcCtD
Pentazocine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00347	0.00525	CcSEcCtD
Pentazocine—Muscle spasms—Pravastatin—atherosclerosis	0.00346	0.00523	CcSEcCtD
Pentazocine—Vision blurred—Niacin—atherosclerosis	0.00345	0.00521	CcSEcCtD
Pentazocine—Confusional state—Ezetimibe—atherosclerosis	0.00344	0.00519	CcSEcCtD
Pentazocine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00341	0.00515	CcSEcCtD
Pentazocine—Vision blurred—Pravastatin—atherosclerosis	0.00339	0.00513	CcSEcCtD
Pentazocine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00338	0.0051	CcSEcCtD
Pentazocine—Tremor—Pravastatin—atherosclerosis	0.00337	0.0051	CcSEcCtD
Pentazocine—Anorexia—Lovastatin—atherosclerosis	0.00331	0.005	CcSEcCtD
Pentazocine—Vertigo—Niacin—atherosclerosis	0.00328	0.00496	CcSEcCtD
Pentazocine—Syncope—Niacin—atherosclerosis	0.00328	0.00495	CcSEcCtD
Pentazocine—Confusional state—Simvastatin—atherosclerosis	0.00328	0.00495	CcSEcCtD
Pentazocine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00325	0.00491	CcSEcCtD
Pentazocine—Vertigo—Pravastatin—atherosclerosis	0.00323	0.00489	CcSEcCtD
Pentazocine—Loss of consciousness—Niacin—atherosclerosis	0.00321	0.00486	CcSEcCtD
Pentazocine—Insomnia—Lovastatin—atherosclerosis	0.00314	0.00475	CcSEcCtD
Pentazocine—Paraesthesia—Lovastatin—atherosclerosis	0.00312	0.00471	CcSEcCtD
Pentazocine—Hypertension—Pravastatin—atherosclerosis	0.00311	0.0047	CcSEcCtD
Pentazocine—Anorexia—Simvastatin—atherosclerosis	0.0031	0.00468	CcSEcCtD
Pentazocine—Dyspnoea—Lovastatin—atherosclerosis	0.0031	0.00468	CcSEcCtD
Pentazocine—Insomnia—Ezetimibe—atherosclerosis	0.00308	0.00466	CcSEcCtD
Pentazocine—Paraesthesia—Ezetimibe—atherosclerosis	0.00306	0.00462	CcSEcCtD
Pentazocine—Dry mouth—Niacin—atherosclerosis	0.00304	0.0046	CcSEcCtD
Pentazocine—Dyspnoea—Ezetimibe—atherosclerosis	0.00304	0.00459	CcSEcCtD
Pentazocine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00302	0.00456	CcSEcCtD
Pentazocine—Decreased appetite—Lovastatin—atherosclerosis	0.00302	0.00456	CcSEcCtD
Pentazocine—Anaphylactic shock—Niacin—atherosclerosis	0.00298	0.00451	CcSEcCtD
Pentazocine—Constipation—Lovastatin—atherosclerosis	0.00297	0.00449	CcSEcCtD
Pentazocine—Confusional state—Pravastatin—atherosclerosis	0.00296	0.00448	CcSEcCtD
Pentazocine—Decreased appetite—Ezetimibe—atherosclerosis	0.00296	0.00448	CcSEcCtD
Pentazocine—Asthenia—Rosuvastatin—atherosclerosis	0.00294	0.00444	CcSEcCtD
Pentazocine—Insomnia—Simvastatin—atherosclerosis	0.00294	0.00444	CcSEcCtD
Pentazocine—Anaphylactic shock—Pravastatin—atherosclerosis	0.00294	0.00444	CcSEcCtD
Pentazocine—Shock—Niacin—atherosclerosis	0.00294	0.00444	CcSEcCtD
Pentazocine—Paraesthesia—Simvastatin—atherosclerosis	0.00292	0.00441	CcSEcCtD
Pentazocine—Constipation—Ezetimibe—atherosclerosis	0.00291	0.0044	CcSEcCtD
Pentazocine—Tachycardia—Niacin—atherosclerosis	0.00291	0.0044	CcSEcCtD
Pentazocine—Pruritus—Rosuvastatin—atherosclerosis	0.0029	0.00438	CcSEcCtD
Pentazocine—Dyspnoea—Simvastatin—atherosclerosis	0.0029	0.00438	CcSEcCtD
Pentazocine—Hyperhidrosis—Niacin—atherosclerosis	0.00288	0.00436	CcSEcCtD
Pentazocine—Feeling abnormal—Lovastatin—atherosclerosis	0.00286	0.00433	CcSEcCtD
Pentazocine—Anorexia—Niacin—atherosclerosis	0.00284	0.0043	CcSEcCtD
Pentazocine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00284	0.00429	CcSEcCtD
Pentazocine—Decreased appetite—Simvastatin—atherosclerosis	0.00282	0.00427	CcSEcCtD
Pentazocine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00281	0.00424	CcSEcCtD
Pentazocine—Diarrhoea—Rosuvastatin—atherosclerosis	0.0028	0.00424	CcSEcCtD
Pentazocine—Anorexia—Pravastatin—atherosclerosis	0.0028	0.00423	CcSEcCtD
Pentazocine—Hypotension—Niacin—atherosclerosis	0.00279	0.00421	CcSEcCtD
Pentazocine—Constipation—Simvastatin—atherosclerosis	0.00278	0.0042	CcSEcCtD
Pentazocine—Dizziness—Rosuvastatin—atherosclerosis	0.00271	0.0041	CcSEcCtD
Pentazocine—Insomnia—Niacin—atherosclerosis	0.0027	0.00408	CcSEcCtD
Pentazocine—Paraesthesia—Niacin—atherosclerosis	0.00268	0.00405	CcSEcCtD
Pentazocine—Feeling abnormal—Simvastatin—atherosclerosis	0.00268	0.00405	CcSEcCtD
Pentazocine—Dyspnoea—Niacin—atherosclerosis	0.00266	0.00402	CcSEcCtD
Pentazocine—Insomnia—Pravastatin—atherosclerosis	0.00266	0.00401	CcSEcCtD
Pentazocine—Somnolence—Niacin—atherosclerosis	0.00265	0.00401	CcSEcCtD
Pentazocine—Paraesthesia—Pravastatin—atherosclerosis	0.00264	0.00399	CcSEcCtD
Pentazocine—Dyspnoea—Pravastatin—atherosclerosis	0.00262	0.00396	CcSEcCtD
Pentazocine—Decreased appetite—Niacin—atherosclerosis	0.00259	0.00392	CcSEcCtD
Pentazocine—Dermatitis—Rosuvastatin—atherosclerosis	0.00258	0.0039	CcSEcCtD
Pentazocine—Headache—Rosuvastatin—atherosclerosis	0.00257	0.00388	CcSEcCtD
Pentazocine—Hypersensitivity—Lovastatin—atherosclerosis	0.00256	0.00387	CcSEcCtD
Pentazocine—Decreased appetite—Pravastatin—atherosclerosis	0.00255	0.00386	CcSEcCtD
Pentazocine—Constipation—Pravastatin—atherosclerosis	0.00251	0.0038	CcSEcCtD
Pentazocine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00251	0.00379	CcSEcCtD
Pentazocine—Asthenia—Lovastatin—atherosclerosis	0.00249	0.00377	CcSEcCtD
Pentazocine—Pruritus—Lovastatin—atherosclerosis	0.00246	0.00371	CcSEcCtD
Pentazocine—Asthenia—Ezetimibe—atherosclerosis	0.00244	0.00369	CcSEcCtD
Pentazocine—Nausea—Rosuvastatin—atherosclerosis	0.00244	0.00368	CcSEcCtD
Pentazocine—Feeling abnormal—Pravastatin—atherosclerosis	0.00242	0.00366	CcSEcCtD
Pentazocine—Pruritus—Ezetimibe—atherosclerosis	0.00241	0.00364	CcSEcCtD
Pentazocine—Hypersensitivity—Simvastatin—atherosclerosis	0.00239	0.00362	CcSEcCtD
Pentazocine—Diarrhoea—Lovastatin—atherosclerosis	0.00238	0.00359	CcSEcCtD
Pentazocine—Asthenia—Simvastatin—atherosclerosis	0.00233	0.00352	CcSEcCtD
Pentazocine—Diarrhoea—Ezetimibe—atherosclerosis	0.00233	0.00352	CcSEcCtD
Pentazocine—Pruritus—Simvastatin—atherosclerosis	0.0023	0.00347	CcSEcCtD
Pentazocine—Dizziness—Lovastatin—atherosclerosis	0.0023	0.00347	CcSEcCtD
Pentazocine—Dizziness—Ezetimibe—atherosclerosis	0.00225	0.0034	CcSEcCtD
Pentazocine—Diarrhoea—Simvastatin—atherosclerosis	0.00222	0.00336	CcSEcCtD
Pentazocine—Vomiting—Lovastatin—atherosclerosis	0.00221	0.00334	CcSEcCtD
Pentazocine—Hypersensitivity—Niacin—atherosclerosis	0.0022	0.00332	CcSEcCtD
Pentazocine—Dermatitis—Lovastatin—atherosclerosis	0.00219	0.00331	CcSEcCtD
Pentazocine—Headache—Lovastatin—atherosclerosis	0.00218	0.00329	CcSEcCtD
Pentazocine—Vomiting—Ezetimibe—atherosclerosis	0.00217	0.00327	CcSEcCtD
Pentazocine—Hypersensitivity—Pravastatin—atherosclerosis	0.00216	0.00327	CcSEcCtD
Pentazocine—Dizziness—Simvastatin—atherosclerosis	0.00215	0.00325	CcSEcCtD
Pentazocine—Dermatitis—Ezetimibe—atherosclerosis	0.00215	0.00324	CcSEcCtD
Pentazocine—Asthenia—Niacin—atherosclerosis	0.00214	0.00323	CcSEcCtD
Pentazocine—Headache—Ezetimibe—atherosclerosis	0.00213	0.00323	CcSEcCtD
Pentazocine—Pruritus—Niacin—atherosclerosis	0.00211	0.00319	CcSEcCtD
Pentazocine—Asthenia—Pravastatin—atherosclerosis	0.00211	0.00318	CcSEcCtD
Pentazocine—Pruritus—Pravastatin—atherosclerosis	0.00208	0.00314	CcSEcCtD
Pentazocine—Vomiting—Simvastatin—atherosclerosis	0.00207	0.00312	CcSEcCtD
Pentazocine—Nausea—Lovastatin—atherosclerosis	0.00206	0.00312	CcSEcCtD
Pentazocine—Dermatitis—Simvastatin—atherosclerosis	0.00205	0.00309	CcSEcCtD
Pentazocine—Diarrhoea—Niacin—atherosclerosis	0.00204	0.00308	CcSEcCtD
Pentazocine—Headache—Simvastatin—atherosclerosis	0.00204	0.00308	CcSEcCtD
Pentazocine—Nausea—Ezetimibe—atherosclerosis	0.00202	0.00306	CcSEcCtD
Pentazocine—Diarrhoea—Pravastatin—atherosclerosis	0.00201	0.00304	CcSEcCtD
Pentazocine—Dizziness—Niacin—atherosclerosis	0.00197	0.00298	CcSEcCtD
Pentazocine—Dizziness—Pravastatin—atherosclerosis	0.00194	0.00294	CcSEcCtD
Pentazocine—Nausea—Simvastatin—atherosclerosis	0.00193	0.00292	CcSEcCtD
Pentazocine—Vomiting—Niacin—atherosclerosis	0.0019	0.00287	CcSEcCtD
Pentazocine—Dermatitis—Niacin—atherosclerosis	0.00188	0.00284	CcSEcCtD
Pentazocine—Headache—Niacin—atherosclerosis	0.00187	0.00282	CcSEcCtD
Pentazocine—Vomiting—Pravastatin—atherosclerosis	0.00187	0.00282	CcSEcCtD
Pentazocine—Dermatitis—Pravastatin—atherosclerosis	0.00185	0.0028	CcSEcCtD
Pentazocine—Headache—Pravastatin—atherosclerosis	0.00184	0.00278	CcSEcCtD
Pentazocine—Nausea—Niacin—atherosclerosis	0.00177	0.00268	CcSEcCtD
Pentazocine—Nausea—Pravastatin—atherosclerosis	0.00175	0.00264	CcSEcCtD
Pentazocine—OPRD1—Signaling by GPCR—KNG1—atherosclerosis	0.000248	0.000734	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—GHRL—atherosclerosis	0.000248	0.000733	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—UTS2—atherosclerosis	0.000247	0.000731	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AGTR1—atherosclerosis	0.000247	0.00073	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CCL2—atherosclerosis	0.000244	0.000723	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL4—atherosclerosis	0.000243	0.00072	CbGpPWpGaD
Pentazocine—EBP—Metabolism—ALB—atherosclerosis	0.000241	0.000713	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—KNG1—atherosclerosis	0.00024	0.000709	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000238	0.000705	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL3—atherosclerosis	0.000238	0.000703	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CX3CR1—atherosclerosis	0.000237	0.000701	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CASR—atherosclerosis	0.000237	0.000701	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000237	0.0007	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CCR2—atherosclerosis	0.000237	0.0007	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CX3CL1—atherosclerosis	0.000233	0.000688	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—F2—atherosclerosis	0.000232	0.000685	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—GHRL—atherosclerosis	0.000231	0.000683	CbGpPWpGaD
Pentazocine—EBP—Metabolism—NOS3—atherosclerosis	0.000231	0.000682	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—EDN1—atherosclerosis	0.00023	0.000681	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CCL5—atherosclerosis	0.000229	0.000676	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOA2—atherosclerosis	0.000227	0.000672	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOA4—atherosclerosis	0.000223	0.00066	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CNR2—atherosclerosis	0.00022	0.000652	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CXCL8—atherosclerosis	0.00022	0.000652	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MMP3—atherosclerosis	0.00022	0.00065	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—KNG1—atherosclerosis	0.000218	0.000644	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000217	0.000643	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—UTS2—atherosclerosis	0.000217	0.000641	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AGTR1—atherosclerosis	0.000216	0.00064	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—EDNRA—atherosclerosis	0.000215	0.000636	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCR2—atherosclerosis	0.000215	0.000636	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000214	0.000634	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PTGS2—atherosclerosis	0.000211	0.000624	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—GHRL—atherosclerosis	0.00021	0.00062	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—EDN1—atherosclerosis	0.000209	0.000619	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CX3CR1—atherosclerosis	0.000208	0.000615	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CASR—atherosclerosis	0.000208	0.000615	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCL5—atherosclerosis	0.000208	0.000614	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCL2—atherosclerosis	0.000207	0.000611	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL4—atherosclerosis	0.000206	0.000608	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CX3CL1—atherosclerosis	0.000204	0.000603	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—KNG1—atherosclerosis	0.000203	0.000599	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—EDN1—atherosclerosis	0.000202	0.000597	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000201	0.000596	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CCL5—atherosclerosis	0.0002	0.000593	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PRKCG—atherosclerosis	0.000197	0.000584	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VWF—atherosclerosis	0.000196	0.000581	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOC3—atherosclerosis	0.000195	0.000577	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LDLR—atherosclerosis	0.000194	0.000574	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CNR2—atherosclerosis	0.000193	0.000572	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CXCL8—atherosclerosis	0.000193	0.000571	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MMP3—atherosclerosis	0.000193	0.00057	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOA2—atherosclerosis	0.000192	0.000568	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AGT—atherosclerosis	0.000191	0.000566	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000191	0.000564	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL3—atherosclerosis	0.00019	0.000561	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—KNG1—atherosclerosis	0.000184	0.000544	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—EDN1—atherosclerosis	0.000183	0.000543	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—UTS2—atherosclerosis	0.000183	0.000542	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AGTR1—atherosclerosis	0.000183	0.000541	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCL5—atherosclerosis	0.000182	0.000538	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NCF1—atherosclerosis	0.000182	0.000537	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—F2—atherosclerosis	0.000177	0.000523	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CX3CR1—atherosclerosis	0.000176	0.00052	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CASR—atherosclerosis	0.000176	0.00052	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AGT—atherosclerosis	0.000174	0.000514	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PRKCG—atherosclerosis	0.000173	0.000512	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CX3CL1—atherosclerosis	0.000172	0.00051	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VWF—atherosclerosis	0.000172	0.00051	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCR2—atherosclerosis	0.000171	0.000507	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EDNRA—atherosclerosis	0.000171	0.000507	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOC3—atherosclerosis	0.000171	0.000506	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—EDN1—atherosclerosis	0.000171	0.000505	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CYBA—atherosclerosis	0.000171	0.000505	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LDLR—atherosclerosis	0.00017	0.000503	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CCL5—atherosclerosis	0.000169	0.000501	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000169	0.0005	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AGT—atherosclerosis	0.000168	0.000496	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PLAT—atherosclerosis	0.000167	0.000494	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PARP1—atherosclerosis	0.000167	0.000494	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GHRL—atherosclerosis	0.000167	0.000494	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL3—atherosclerosis	0.000166	0.000492	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CNR2—atherosclerosis	0.000163	0.000483	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CXCL8—atherosclerosis	0.000163	0.000483	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MMP3—atherosclerosis	0.000163	0.000482	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000161	0.000476	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—F2—atherosclerosis	0.00016	0.000475	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NCF1—atherosclerosis	0.000159	0.000471	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—EDN1—atherosclerosis	0.000155	0.000459	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—F2—atherosclerosis	0.000155	0.000458	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL5—atherosclerosis	0.000154	0.000455	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000154	0.000454	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AGT—atherosclerosis	0.000152	0.00045	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCR2—atherosclerosis	0.00015	0.000445	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EDNRA—atherosclerosis	0.00015	0.000445	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CYBA—atherosclerosis	0.00015	0.000443	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000148	0.000438	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KNG1—atherosclerosis	0.000147	0.000434	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GHRL—atherosclerosis	0.000147	0.000433	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PLAT—atherosclerosis	0.000147	0.000433	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PARP1—atherosclerosis	0.000147	0.000433	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PRKCG—atherosclerosis	0.000146	0.000433	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AGTR1—atherosclerosis	0.000146	0.000431	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VWF—atherosclerosis	0.000146	0.000431	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOC3—atherosclerosis	0.000145	0.000428	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LDLR—atherosclerosis	0.000144	0.000425	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCL2—atherosclerosis	0.000143	0.000423	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PLG—atherosclerosis	0.000142	0.00042	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AGT—atherosclerosis	0.000142	0.000419	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—F2—atherosclerosis	0.000141	0.000416	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL3—atherosclerosis	0.00014	0.000415	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000135	0.000398	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NCF1—atherosclerosis	0.000135	0.000398	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SOCS3—atherosclerosis	0.000135	0.000398	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—F2—atherosclerosis	0.000131	0.000387	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MMP3—atherosclerosis	0.00013	0.000384	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF2—atherosclerosis	0.000129	0.000383	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AGT—atherosclerosis	0.000129	0.000381	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KNG1—atherosclerosis	0.000129	0.00038	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AGTR1—atherosclerosis	0.000128	0.000378	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR2—atherosclerosis	0.000127	0.000376	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EDNRA—atherosclerosis	0.000127	0.000376	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CYBA—atherosclerosis	0.000126	0.000374	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOB—atherosclerosis	0.000126	0.000371	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCL2—atherosclerosis	0.000125	0.000371	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000125	0.000371	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PLG—atherosclerosis	0.000125	0.000368	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000125	0.000368	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PARP1—atherosclerosis	0.000124	0.000366	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GHRL—atherosclerosis	0.000124	0.000366	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PLAT—atherosclerosis	0.000124	0.000366	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EDN1—atherosclerosis	0.000124	0.000365	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL5—atherosclerosis	0.000123	0.000363	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LPL—atherosclerosis	0.00012	0.000355	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—F2—atherosclerosis	0.000119	0.000352	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SOCS3—atherosclerosis	0.000118	0.000349	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCG—atherosclerosis	0.000117	0.000345	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MMP3—atherosclerosis	0.000114	0.000337	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000114	0.000337	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SPP1—atherosclerosis	0.000114	0.000336	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF2—atherosclerosis	0.000113	0.000335	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL8—atherosclerosis	0.000113	0.000334	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOB—atherosclerosis	0.00011	0.000326	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000109	0.000323	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KNG1—atherosclerosis	0.000109	0.000321	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EDN1—atherosclerosis	0.000108	0.00032	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AGTR1—atherosclerosis	0.000108	0.000319	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL5—atherosclerosis	0.000108	0.000318	CbGpPWpGaD
Pentazocine—EBP—Metabolism—AKT1—atherosclerosis	0.000106	0.000314	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL2—atherosclerosis	0.000106	0.000313	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PLG—atherosclerosis	0.000105	0.000311	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LPL—atherosclerosis	0.000105	0.000311	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PDGFB—atherosclerosis	0.000105	0.000311	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AGT—atherosclerosis	0.000103	0.000303	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCG—atherosclerosis	0.000102	0.000302	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOE—atherosclerosis	0.000101	0.000297	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LEP—atherosclerosis	0.000101	0.000297	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SOCS3—atherosclerosis	9.97e-05	0.000295	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SPP1—atherosclerosis	9.96e-05	0.000295	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CAV1—atherosclerosis	9.96e-05	0.000295	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOA1—atherosclerosis	9.94e-05	0.000294	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL8—atherosclerosis	9.91e-05	0.000293	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MMP3—atherosclerosis	9.63e-05	0.000285	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ESR1—atherosclerosis	9.6e-05	0.000284	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF2—atherosclerosis	9.59e-05	0.000284	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—F2—atherosclerosis	9.48e-05	0.00028	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOB—atherosclerosis	9.31e-05	0.000275	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	9.23e-05	0.000273	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PDGFB—atherosclerosis	9.21e-05	0.000272	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EDN1—atherosclerosis	9.16e-05	0.000271	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL5—atherosclerosis	9.09e-05	0.000269	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CG—atherosclerosis	9.07e-05	0.000268	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AGT—atherosclerosis	9e-05	0.000266	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LPL—atherosclerosis	8.89e-05	0.000263	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOE—atherosclerosis	8.81e-05	0.000261	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LEP—atherosclerosis	8.81e-05	0.000261	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CAV1—atherosclerosis	8.73e-05	0.000258	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOA1—atherosclerosis	8.71e-05	0.000258	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MAPK3—atherosclerosis	8.69e-05	0.000257	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	8.64e-05	0.000256	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—INS—atherosclerosis	8.59e-05	0.000254	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL2—atherosclerosis	8.45e-05	0.00025	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SPP1—atherosclerosis	8.42e-05	0.000249	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ESR1—atherosclerosis	8.41e-05	0.000249	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	8.38e-05	0.000248	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—F2—atherosclerosis	8.31e-05	0.000246	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF1—atherosclerosis	8.31e-05	0.000246	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CG—atherosclerosis	7.95e-05	0.000235	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SERPINE1—atherosclerosis	7.89e-05	0.000233	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	7.79e-05	0.00023	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MAPK3—atherosclerosis	7.62e-05	0.000225	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AGT—atherosclerosis	7.6e-05	0.000225	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOS3—atherosclerosis	7.53e-05	0.000223	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—INS—atherosclerosis	7.53e-05	0.000223	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LEP—atherosclerosis	7.45e-05	0.00022	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOE—atherosclerosis	7.45e-05	0.00022	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL2—atherosclerosis	7.41e-05	0.000219	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CAV1—atherosclerosis	7.38e-05	0.000218	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOA1—atherosclerosis	7.36e-05	0.000218	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF1—atherosclerosis	7.28e-05	0.000215	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ESR1—atherosclerosis	7.11e-05	0.00021	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—F2—atherosclerosis	7.02e-05	0.000208	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SERPINE1—atherosclerosis	6.92e-05	0.000205	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	6.72e-05	0.000199	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL8—atherosclerosis	6.68e-05	0.000198	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOS3—atherosclerosis	6.6e-05	0.000195	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AKT1—atherosclerosis	6.45e-05	0.000191	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	6.44e-05	0.00019	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—INS—atherosclerosis	6.36e-05	0.000188	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—atherosclerosis	6.35e-05	0.000188	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL2—atherosclerosis	6.26e-05	0.000185	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF1—atherosclerosis	6.16e-05	0.000182	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MMP9—atherosclerosis	6.04e-05	0.000179	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NFKB1—atherosclerosis	5.98e-05	0.000177	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK8—atherosclerosis	5.88e-05	0.000174	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AKT1—atherosclerosis	5.86e-05	0.000173	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL8—atherosclerosis	5.86e-05	0.000173	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	5.85e-05	0.000173	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AKT1—atherosclerosis	5.66e-05	0.000167	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOS3—atherosclerosis	5.58e-05	0.000165	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—atherosclerosis	5.57e-05	0.000165	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VEGFA—atherosclerosis	5.43e-05	0.00016	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STAT3—atherosclerosis	5.37e-05	0.000159	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MMP9—atherosclerosis	5.3e-05	0.000157	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NFKB1—atherosclerosis	5.24e-05	0.000155	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK8—atherosclerosis	5.15e-05	0.000152	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AKT1—atherosclerosis	5.14e-05	0.000152	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK3—atherosclerosis	5.13e-05	0.000152	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TGFB1—atherosclerosis	4.98e-05	0.000147	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	4.95e-05	0.000146	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	4.78e-05	0.000141	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VEGFA—atherosclerosis	4.76e-05	0.000141	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STAT3—atherosclerosis	4.71e-05	0.000139	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—atherosclerosis	4.71e-05	0.000139	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK3—atherosclerosis	4.5e-05	0.000133	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MMP9—atherosclerosis	4.48e-05	0.000132	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	4.43e-05	0.000131	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TGFB1—atherosclerosis	4.37e-05	0.000129	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	4.35e-05	0.000129	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	4.34e-05	0.000128	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	4.02e-05	0.000119	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT3—atherosclerosis	3.98e-05	0.000118	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	3.8e-05	0.000112	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—atherosclerosis	3.75e-05	0.000111	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	3.69e-05	0.000109	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT1—atherosclerosis	3.46e-05	0.000102	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—atherosclerosis	3.29e-05	9.73e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT1—atherosclerosis	3.04e-05	8.98e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—atherosclerosis	2.78e-05	8.22e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT1—atherosclerosis	2.57e-05	7.59e-05	CbGpPWpGaD
